Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityActive in the last 2 years

Huimin Huang

Matched on ORCID iD 0000-0003-0038-4334; OpenAlex author ID A5101435439. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2021: 1 paper · 2022: 3 papers · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 7

  1. BCAT1 inhibits glutamine-dependent Akt/mTOR signaling and nucleotide synthesis by initiating BTRC-mediated degradation of SLC3A2 in pancreatic adenocarcinoma. Co-author DOI 10.1186/s40170-026-00436-3↗
  2. Lactate enhances NMNAT1 lactylation to sustain nuclear NAD+ salvage pathway and promote survival of pancreatic adenocarcinoma cells under glucose-deprived cond… Co-author DOI 10.1016/j.canlet.2024.216806↗
  3. Construction of a metabolism-related gene prognostic model to predict survival of pancreatic cancer patients. Co-author DOI 10.1016/j.heliyon.2022.e12378↗
  4. Synthetic oleanane triterpenoid derivative CDDO-Me disrupts cellular bioenergetics to suppress pancreatic ductal adenocarcinoma via targeting SLC1A5. First author DOI 10.1002/jbt.23192↗
  5. 6-methoxydihydroavicine, the alkaloid extracted from Macleaya cordata (Willd.) R. Br. (Papaveraceae), triggers RIPK1/Caspase-dependent cell death in pancreatic… Co-author DOI 10.1016/j.phymed.2022.154164↗
  6. A synthesized olean-28,13β-lactam targets YTHDF1-GLS1 axis to induce ROS-dependent metabolic crisis and cell death in pancreatic adenocarcinoma. Co-author DOI 10.1186/s12935-022-02562-6↗
  7. CXCL10 is a Tumor Microenvironment and Immune Infiltration Related Prognostic Biomarker in Pancreatic Adenocarcinoma. Co-author DOI 10.3389/fmolb.2021.611508↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Linhua Lan · 7 shared papers, 2021–2026 · strength 1.30
  2. Guihua Jin · 5 shared papers, 2022–2026 · strength 0.93
  3. Shijia Wu · 3 shared papers, 2022 · strength 0.43
  4. Percy David Papa Akuetteh · 2 shared papers, 2022 · strength 0.29
  5. Fugen Shangguan · 2 shared papers, 2022 · strength 0.29
  6. Liyi Li · 1 shared paper, 2023 · strength 0.20
  7. Xiaoqun Zheng · 1 shared paper, 2024 · strength 0.19
  8. Hongping Xia · 1 shared paper, 2024 · strength 0.19
  9. Hongbao Yang · 1 shared paper, 2022 · strength 0.15
  10. Qiyu Zhang · 1 shared paper, 2022 · strength 0.15
  11. Nengfang Ma · 1 shared paper, 2022 · strength 0.14
  12. Hongping Xia · 1 shared paper, 2022 · strength 0.14
  13. Hailong Yang · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.